XBiotech company info

What does XBiotech do?
XBiotech (NASDAQ:XBIT) is a biopharmaceutical company engaged in discovering, developing, and commercializing novel antibodies for various diseases. The company's diverse pipeline focuses on addressing unmet medical needs in multiple therapeutic areas, emphasizing oncology, infectious diseases, and inflammatory conditions. XBiotech employs a proprietary technology platform to create unique therapeutic antibodies that aim to improve patient outcomes. Their mission revolves around harnessing the power of natural immunity to transform treatment paradigms and enhance the quality of life for patients globally. By concentrating on innovation and leveraging its research and development expertise, XBiotech strives to advance its projects from discovery through clinical development, aiming to bring groundbreaking treatments to the market.
XBiotech company media
Company Snapshot

Is XBiotech a public or private company?

key
Ownership
Public

How many people does XBiotech employ?

people
Employees
82

What sector is XBiotech in?

pie chart
Sector
Health Care

Where is the head office for XBiotech?

location pin
Head Office
Austin, United States

What year was XBiotech founded?

founded flag
Year Founded
2005
What does XBiotech specialise in?
/True Human Antibodies /Immunotherapy Research /Anti-Inflammatory Drugs /Cancer Treatment /Clinical Trials /Bermekimab Development

What are the products and/or services of XBiotech?

Overview of XBiotech offerings
MABp1, a first-in-class True Human monoclonal antibody targeting IL-1? for treating chronic inflammatory diseases and cancers.
A COVID-19 therapy project aimed at developing a potent neutralizing antibody treatment for coronavirus infections.
Research on cardiovascular diseases focusing on therapeutic antibodies to prevent and treat heart disease.
Collaborations to develop antibody therapies for a range of infectious diseases, including potential treatments for HIV.
Pipeline expansion efforts include identifying and developing new True Human antibodies for various inflammatory conditions and cancers.

Who is in the executive team of XBiotech?

XBiotech leadership team
  • Mr. John  Simard
    Mr. John Simard
    Founder, President, CEO & Chairman
  • Dr. Sushma  Shivaswamy Ph.D.
    Dr. Sushma Shivaswamy Ph.D.
    Chief Scientific Officer
  • Ms. Angela  Hu
    Ms. Angela Hu
    Director of Finance, Principal Financial & Accounting Officer and Financial Controller